Bristol Myers rises after lifting FY profit forecast, topping quarterly estimates

Shares of drugmaker Bristol-Myers Squibb BMY.N rise 1.4% to $49.21 premarket

Co raises 2025 profit forecast to $6.70 to $7 a share, compared with a previous range of $6.55 to $6.85

Analysts on average were expecting annual profit of $6.74/share, as per data compiled by LSEG

BMY posts Q1 revenue of $11.2 billion, exceeding Wall Street estimates of $10.7 billion

Co reports Q1 adj. profit of $1.80/share vs analysts' average estimate of $1.49/share

As of last close, BMY stock down 14.2% YTD